The eŠects of vanadate on lipoprotein lipase (LPL), a lipid metabolizing enzyme, were tested using isolated rat fat pads. Vanadate increased the cellular LPL content through the stimulation of intracellular transport of the enzyme for activation, probably glycosylation. The stimulated release of LPL from the fat pads by vanadate was due to the increase in intracellular Ca 2＋ concentration, leading to the fusion of plasma membrane with vehicle included active LPL. Although vanadate shows insulinand heparin mimicking eŠects, it appears to diŠer from both insulin and heparin with regard to the mechanism of action. In isolated mouse fat pads, vanadate decreased the cellular leptin content and secretion by the increased degradation via a cAMP/PKA dependent process involving proteasome activation and/or ubiquitination. This was the reverse of the action of insulin. In hepatocytes, cAMP phosphodiesterase type 3 activity was stimulated via the increased mitogen activated protein kinase activity by vanadate. On the other hand, the stimulation by insulin was dependent on Akt kinase activation. The eŠects of vanadate were additive to those of insulin, suggesting that vanadate diŠers from insulin with regard to the receptor signaling cascade. Furthermore, vanadate showed antiplatelet and antithrombin activity, leading to the prolongation of blood clotting time. 
The fat pads were incubated with vanadate (2 mM, •), insulin (3 nM, ▲), or neither one (○) in Krebs Ringer bicarbonate buŠer containing 5 mM glucose and 2％ serum albumin, pH 7.4, (KRBGA) for up to 150 min. The incubated fat pads were homogenized and centrifuged. The resultant supernatant was used as crude LPL solution. The activity was assayed using the activated intralipos in the presence or absence of 1 M NaCl. The LPL activity calculated from values reduced in the presence of 1 M NaCl is expressed as mmol free fatty acids (FFA) produced per h per g fat pads. The fat pads were preincubated with monensin at the indicated concentrations for 15 min and further incubated with vanadate (2 mM, •), insulin (3 nM, ▲), or neither one (○) for 120 min. The fat pads were incubated with vanadate (2 mM, •), heparin (5 U/ ml, ▲), or neither one (○) for up to 150 min. The incubated fat pads were removed by centrifugation, and the resultant solution was used as the enzyme solution. The fat pads were preincubated with quin 2 AM at the indicated concentrations for 15 min and further incubated with vanadate (2 mM, •), heparin (10 U/ml, ▲), or neither one (○) for 90 min. The fat pads were incubated with vanadate (2 mM, •) or insulin (15 nM, ○) for the indicated periods. The incubated fat pads were quickly frozen to terminate the reaction and homogenized in cold 12.5％ trichloroacetic acid. The IP 3 amount was determined using an IP 3 determination kit. The fat pads were incubated with 2 mM vanadate, 700 nM insulin, or neither one for up to 4 h. The incubated fat pads were removed by centrifugation, and the resultant solution was used as the leptin solution. Samples were subjected to SDS PAGE followed by Western immunoblot analysis using anti leptin antibody. The relative amount of leptin was determined by comparing the integrated density against known leptin standards. Signiˆcant diŠerences compared with the control group at each time:  p＜0.01 and   p ＜0.001. The fat pads, which were incubated with 1 mM vanadate, 700 nM insulin, or neither one for up to 4 h, were homogenized and centrifuged. The infranatant was further centrifuged. The resultant supernatant was used to determine the intracellular leptin content. Data are the mean±SE from four diŠerent experiments, each performed in duplicate. Signiˆcant diŠerences compared with the control group at each time:  p＜0.05 and   p＜0.01. The fat pads incubated with or without 1 mM vanadate for 2 h were homogenized, sonicated, and centrifuged. After centrifugation of the infranatant, the resultant supernatant was used as the proteasome fraction.
[ 125 I]Leptin was incubated with the proteasome fraction in the absence or presence of an ubiquitination and/or ATP-regenerating system for 1 h. Radioactivity of degraded products is expressed as cpm per mg protein of the proteasome fraction. Results are the mean±SE from four separate experiments, each performed in duplicate. Signiˆcant diŠerences compared with the vanadate-treated group in the presence of an ubiquitination system without ATP:  p＜0.05. The adipocytes and fat pads were incubated with or without 2 mM vanadate for 60 min. Km and Vmax values were calculated from double reciprocal plots of the PDE activity in a range of substrate (cAMP) concentrations of 0.17  2 mM.
Fig. 14. Time Course of Stimulation of PKC Activity by Vanadate
The fat pads were incubated with 2 mM vanadate (•), 3 nM insulin (▲), or neither one (○) for up to 150 min. The PKC activities in the particulate fractions were determined with a PKC enzyme assay system kit. The fat pads were incubated with vanadate at the indicated concentrations for 60 min, homogenized, and centrifuged. Enzymatic activities in the resultant particulate fractions were assayed using each substrate. A: PTK activity against poly(Glu4, Tyr1)copolymer, B: MBPK activity against MBP, C: PDE activity against cAMP. Signiˆcant diŠerences compared with groups without vanadate,  p＜0.05,   p＜0.01. Hepatocytes were incubated with 10 nM insulin for up to 60 min. The PDE3 activity in the particulate and MAPK and Akt activities in the cytosol were assayed using cAMP, a p42/p44 MAP kinase enzyme assay system, and Akt substrate, respectively. Signiˆcant diŠerences compared with the control group at each time,  p＜0.05,   p＜0.01. Hepatocytes were incubated with 100 mM vanadate for up to 60 min. The PKA activity in the cytosol separated was determined using a PKA assay kit. Signiˆcant diŠerences compared with the control group at each time,  p＜ 0.05,   p＜0.01. Hepatocytes were incubated with 100 or 1000 mM vanadate or 10 nM insulin for 10 min. The cells lysed in 1％ Triton X 100 were centrifuged to remove insoluble materials and subjected to SDS PAGE followed by Western immunoblot analysis using anti-phosphotyrosine IgG. Band intensities were estimated with Lane Analyzer 2, and densitometry data were plotted as the percentage of the control. Normal human plasma was preincubated at the indicated concentrations of vanadate in 50 mM Tris HCl buŠer, pH 7.9, containing 50 mM NaCl at 37°C for 15 min and further incubated with kaolin for 3 min. The determination of clotting time was started by the addition of CaCl2-cephalin to the kaolin-treated mixture. The plasma was preincubated with vanadate at 37°C for 15 min in the presence or absence of heparin (2.5 mU/ml), before the determination of clotting time. 
